We are international
Donate
TEXT SIZE   


ASH 2011: Dr Terragna - A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)
Carolina Terragna, PhD
Seràgnoli Institute of Hematology
Bologna, Italy
12.07.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles